Con esta herramienta te facilitamos un acceso a todas las ofertas y demandas de tecnología europeas y a búsquedas de socios para participar en propuestas europeas de I+D publicadas en la red Enterprise Europe Network, pudiendo filtrar los resultados para facilitar las búsquedas más acordes con tus necesidades.

¿Quieres recibir estos listados de oportunidades de colaboración en tu correo de forma periódica y personalizada? Date de alta en nuestro Boletín

Para optimizar los resultados de la búsqueda, se recomienda utilizar términos en inglés.

Grupo de investigación académica croata ofrece su base de datos de anticuerpos

Resumen

Tipo:
Oferta Tecnológica
Referencia:
TOHR20180614001
Publicado:
05/04/2019
Caducidad:
05/04/2020
Resumen:
Un grupo de investigación académica croata especializado en el campo de desarrollo de anticuerpos monoclonales de alto rendimiento (mAb) para aplicaciones vanguardistas, incluyendo análisis del proteoma, ofrece su colección de mAb. La oferta también incluye la producción personalizada de proteínas, anticuerpos monoclonales y líneas celulares de hibridoma. El campo de aplicación potencial se encuentra en el ámbito industrial y académico global para investigación y desarrollo de terapias experimentales. El grupo de investigación genera constantemente mAbs de alta calidad, que han sido demandados por usuarios industriales y académicos de todo el mundo debido a su gran importancia en los estudios de patogénesis de enfermedades virales. El grupo de investigación busca socios con el fin de establecer acuerdos de licencia no exclusivos, servicio o investigación conjunta.

Details

Tittle:
Croatian academic research group offers its database of antibodies
Summary:
A Croatian academic research group active in the field of high-throughput monoclonal antibodies (mAb) development for cutting-edge applications, including proteome analysis offers its collection of mAb. Additionally, the offer includes customized production of proteins. The potential application field is industry and academia worldwide, for research and experimental therapies.
The center is interested in non-exclusive licensing agreements or service agreement and joint research.
Description:
This higher education institution was established in Croatia in 1955. The research centre offering the technology was established in 2006, as a part of the higher education institution with focus on high-throughput monoclonal antibodies (mAb) development for cutting-edge applications, including proteome analysis. Its expertise lies in the field of in vivo immunology, regulation of innate and adaptive immunity and pathogenesis of murine cytomegalovirus (MCMV). It also disposes of several hundred hybridoma cell lines secreting mAbs to a large variety of target proteins.
The research centre is offering a database of mAbs, a collection covering proteins of Varicella-Zoster Virus (VZV), mouse cytomegalovirus (MCMV), human cytomegalovirus (HCMV) and human (mostly) and mouse lymphocytes receptors and their ligands.
The database is a collection of monoclonal antibodies (mAbs). For most of the targeted proteins, there is no other antibody available.
In addition, the offer includes customized production of proteins, monoclonal antibodies and hybridoma cell lines:
1. Expression of proteins of interest as an essential component of the monoclonal antibody (mAb) development process.
2. Multiple immunizations of Balb/c mice or specified mouse strain(s).
3. Generation of custom hybridoma cell lines stably secreting mouse mAbs specific to your target protein.
4. Large scale production of antibodies: in vitro bioreactor mAb production and purification. Antibodies´ testing by different techniques.
The research centre is interested in collaborating with:
· an industry partner interested in non-exclusive licensing agreements or services agreement, preferably with an expertise in sales of biological materials
· academic institutions interested in joint fundamental research, development of research tools and reagents, innovative diagnostic and therapeutic products, with expertise in the area of immunology and virology research.
The reason why the client is interested in cooperation is expanding business internationally.
Advantages and Innovations:
The database represents a collection of monoclonal antibodies (mAbs). For most of the targeted proteins, there is no other antibody available.
The research group continuously generates mAbs of the highest quality, which have been demanded by industrial and academic users worldwide due to their great significance in the studies of pathogenesis of viral disease. Their potential applications are also in translational research, including the characterization of diagnostic markers and experimental therapies.
Since its establishment the research group has participated in more than thirty collaborative projects with prestigious research institutes, universities and biotech SMEs from SE Europe, EU and the USA.
Stage of Development:
Already on the market
IPs:
Secret Know-how

Partner sought

Type and Role of Partner Sought:
The client is looking for:
- an industry partner interested in non-exclusive licensing agreements or service agreement (preferably with expertise in sales of biological materials)
- an academic institutions with expertise in the area of immunology and virology research for :
· joint fundamental research,
· development of research tools and reagents,
· innovative diagnostic and therapeutic products.

Client

Type and Size of Client:
University
Already Engaged in Trans-National Cooperation:
Si
Languages Spoken:
English
German
Italian
Slovenian

Keywords

Technology Keywords:
06001012 Investigaciones médicas
06001013 Tecnología médica / ingeniería biomédica
06001006 Vacunas humanas
06001018 Virus, virología / antibióticos / bacteriología